Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
DRUG Bright Minds Biosciences
0.719+0.009+1.27%
Close
01/31 16:00 ET
0.725+0.005+0.74%
Post Mkt Price 01/31 19:43 ET
High
0.740
Open
0.720
Turnover
80.98K
Low
0.710
Pre Close
0.710
Volume
112.16K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Bright Minds Receives Non-compliance Letter From Nasdaq
Bright Minds Biosciences Receives Nasdaq Bid Price Notification
Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) ("Bright Minds" or the "Company") announces that it has received a notification letter (the
Bright Minds Biosciences Announces Resignation of Board Member
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Bright Minds Biosciences ("Bright Minds," "BMB" or the "Company") (NASDAQ:DRUG) (CSE:DRUG), a biotechnology company focused on developing novel drugs for
Marijuana Moment Tweets: New York Lawmakers File Psychedelics Legalization Bill For 2023:
Marijuana Moment Tweets: New York Lawmakers File Psychedelics Legalization Bill For 2023:
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Decreases By 11.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 82
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Declines By 11.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling
Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 6.4%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating)'s share price traded down 6.4% during trading on Tuesday . The stock traded as low as $0.98 and last traded at $1.02. 300,374 shares traded ha
Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement
'DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn: "DEA Is Committed to Ensuring an Adequate and Uninterrupted Supply of Controlled Substances."' - Marijuana Moment
'DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn: "DEA Is Committed to Ensuring an Adequate and Uninterrupted Supply of Controlled Substances."' - Marijuana Mom
Company Overview
More
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
CEO： Mr. Ian McDonald
Market： NASDAQ
Listing Date： 11/08/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet